| Monofer (iron isomaltoside 1000) / Pharmacosmos |
2016-003087-40: Interest of intraveinous iron and tranexamic acid to reduce transfusion in hip fracture patients - HIFIT Study Intérêt du fer intraveineux et de l'acide tranexamique dans la réduction transfusionnelle chez les patients souffrant d'une fracture du col du fémur - Etude HIFIT |
|
|
| Not yet recruiting | 3 | 780 | Europe | MONOFER, EXACYL 500mg-5mL, Solution for injection, MONOFER 1000mg-10mL, EXACYL 500mg-5mL | UHangers, UHAngers | Hip fracture Fracture du col du fémur, Hip Fracture Fracture du col du fémur, Body processes [G] - Bones and nerves physological processes [G11] | | | | |
2019-004583-22: Evaluation of positive effects of iron treatment for patients with the restless legs syndrome, who either received dopaminergic therapy before or not. |
|
|
| Not yet recruiting | 3 | 140 | Europe | Infusion, Monofer 100mg/ml Lösung zur Injektion und Infusion | Medical University of Innsbruck, Medical University of Innsbruck | Restless leg syndorme, Restless leg syndrome, Not possible to specify | | | | |
NCT05251493: Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy |
|
|
| Recruiting | 3 | 280 | Canada | Iron Isomaltoside 1000, ferric derisomaltose, Monoferric DIN 22477777, Iron sucrose, iron sucrose DIN 02502917 | Saskatchewan Health Authority - Regina Area, Saskatchewan Centre for Patient-Oriented Research | Iron Deficiency Anaemia in Childbirth | 12/24 | 02/25 | | |
FORGE, NCT05467319: Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS |
|
|
| Not yet recruiting | 3 | 82 | NA | Ferric Derisomaltose Injection, iron isomaltoside, Monoferric, Monofer, Normal saline | Alberta Health Services, Calgary, Pharmacosmos A/S | Gynecologic Cancer, Anemia, Iron Deficiency, Surgery | 09/23 | 12/23 | | |
NCT05304442: IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department |
|
|
| Recruiting | 3 | 40 | US | Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric], Ferrous Sulfate 65 mg elemental iron (325 mg tablets) | Baylor College of Medicine, Pharmacosmos Therapeutics, Inc. | Anemia, Iron Deficiency, Uterine Bleeding | 10/24 | 10/24 | | |
IIOVS-01, NCT06248749: Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer |
|
|
| Not yet recruiting | 3 | 200 | Canada | IV iron, iron isomaltoside (Monofer, Monoferric) ferric gluconate (FG) iron sucrose (IS) | University of Saskatchewan | Anaemia in Ovarian Carcinoma | 12/28 | 12/29 | | |
NCT05179226: Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia |
|
|
| Recruiting | 3 | 200 | US | Ferric Derisomaltose, Monofer®, Monoferric® | Pharmacosmos A/S | Iron Deficiency, Anaemia in Children | 04/24 | 06/24 | | |
NCT05407987: Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) |
|
|
| Not yet recruiting | 3 | 82 | Canada | Ferric derisomaltose, MONOFERRIC, Placebo | AHS Cancer Control Alberta | Gynecologic Cancer, Anemia, Iron-deficiency | 09/25 | 12/25 | | |
| Recruiting | 3 | 746 | US | Ferric derisomaltose, Monoferric, Ferrous sulfate, Ferosul | Women and Infants Hospital of Rhode Island, Hasbro Children's Hospital, University of Michigan, Washington University School of Medicine | Iron Deficiency Anemia, Pregnancy | 03/27 | 03/27 | | |
